# Comparison of Platelet Mass Index with Total Oxidant/Antioxidant Levels in Intensive Care Unit Patients

## Authors

- Ugur Fahri Yurekli ([ORCID](https://orcid.org/0000-0002-7969-5196)) — S.B.Ü. Sanliurfa Mehmet Akif Inan Education and Research Hospital, Biochemistry, Şanlıurfa, Turkey
- Mehmet Yurekli ([ORCID](https://orcid.org/0009-0005-3690-070X)) — S.B.Ü. Sanliurfa Mehmet Akif Inan Education and Research Hospital, Şanlıurfa, Turkey
- Ahmet Kaya ([ORCID](https://orcid.org/0000-0002-8751-5298)) — S.B.Ü. Sanliurfa Mehmet Akif Inan Education and Research Hospital, Anesthesia Şanlıurfa, Turkey

## Article information

- **Journal:** The Ulutas Medical Journal (Ulutas Med J), ISSN 2149-388X
- **Issue:** Volume 11, Issue 4 (2025), pages 74–79
- **Article type:** Original Article
- **Published online:** 2025-12-25
- **DOI:** [10.5455/umj.20251015073946](https://doi.org/10.5455/umj.20251015073946)
- **Licence:** [CC BY-NC 4.0](https://creativecommons.org/licenses/by-nc/4.0/)
- **Article page:** https://www.ulutasmedicaljournal.com/?mno=290409
- **PDF:** https://www.ulutasmedicaljournal.com/pdf/290409.pdf

## Abstract

Introduction: One of the key mechanisms affecting mortality and morbidity in intensive care unit (ICU) patients is oxidative stress and the accompanying antioxidant defense system. The Platelet Mass Index (PMI) has been proposed as a novel parameter associated with both disease severity and inflammation. This study sought to explore the association between platelet mass index (PMI) and the levels of total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI) in patients admitted to the intensive care unit. Materials and Methods: This prospective study included 152 patients hospitalized in the ICU and 60 healthy individuals as the control group. Blood samples were analyzed to determine TOS, TAS, procalcitonin (PCT), ferritin, C-reactive protein (CRP), mean platelet volume (MPV),white blood cell count (WBC) and platelet count (PLT). Platelet mass index (PMI) was calculated using PLT and MPV values, while OSI was calculated using TOS and TAS results. The obtained data were analyzed statistically. Results: Among ICU patients, levels of PMI, CRP, TOS, and OSI were elevated, while PLT and TAS levels were reduced compared to the control group. No significant clinical correlation was observed between PMI and the other measured variables. Conclusion: PMI may serve as a simple and easily calculable biomarker reflecting oxidative stress levels in ICU patients. These findings suggest that PMI could be used as a supportive parameter for evaluating oxidative stress in intensive care practice.

## Keywords

Platelet Mass Index; total oxidant status; total antioxidant status; oxidative stress index

## How to cite

Yurekli UF, Yurekli M, Kaya A. Comparison of Platelet Mass Index with Total Oxidant/Antioxidant Levels in Intensive Care Unit Patients. Ulutas Med J. 2025;11(4):74-79. doi:10.5455/umj.20251015073946

## References

1. Halliwell B, Gutteridge JM. Free radicals in biology and medicine: Oxford University Press, 2015. https://doi.org/10.1093/acprof:oso/9780198717478.001.0001
2. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. J Clinical Biochemistry. 2004;37(4):277-85. https://doi.org/10.1016/j.clinbiochem.2003.11.015
3. Erel O. A new automated colorimetric method for measuring total oxidant status. J Clinical Biochemistry. 2005;38(12):1103-11. https://doi.org/10.1016/j.clinbiochem.2005.08.008
4. Ayala JC, Grismaldo A, Sequeda-Castaneda LG, Aristizabal-Pachon AF, Morales L. Oxidative Stress in ICU Patients: ROS as Mortality Long-Term Predictor. Antioxidants (Basel). 2021;10(12). https://doi.org/10.3390/antiox10121912
5. Freedman JEJA, thrombosis, biology v. Oxidative stress and platelets. 2008;28(3):s11-s6. https://doi.org/10.1161/atvbaha.107.159178
6. Bath P, Butterworth RJBc, fibrinolysis. Platelet size: measurement, physiology, and vascular disease. 1996;7 (2):157-61.
7. Violi F, Loffredo L, Carnevale R, Pignatelli P, Pastori DJA, signaling r. Atherothrombosis and oxidative stress: mechanisms and management in elderly. 2017;27(14):1083-124. https://doi.org/10.1089/ars.2016.6963
8. Akbayram S, Dogan M, Akgun C, Mukul Y, Peker E, Bay A, et al. The association of oxidant status and antioxidant capacity in children with acute and chronic ITP. J Pediatr Hematol Oncol. 2010;32(4):277-81. https://doi.org/10.1097/mph.0b013e3181d6421f
9. Mishra V, Baines M, Wenstone R, Shenkin A. Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem. 2005;42(Pt 4):269-76. https://doi.org/10.1258/0004563054255461
10. Tajarernmuang P, Phrommintikul A, Limsukon A, Pothirat C, Chittawatanarat KJCcr, practice. The role of mean platelet volume as a predictor of mortality in critically ill patients: a systematic review and meta-analysis. 2016;2016(1):4370834. https://doi.org/10.1155/2016/4370834
11. Ilhan O, Bor M. Platelet mass index and prediction of severity of transient tachypnea of the newborn. Pediatr Int. 2019;61(7):697-705. https://doi.org/10.1111/ped.13899
12. Krishnamurthy HK, Pereira M, Rajavelu I, Jayaraman V, Krishna K, Wang T, et al. Oxidative stress: fundamentals and advances in quantification techniques. Front Chem. 2024;12:1470458. https://doi.org/10.3389/fchem.2024.1470458
13. Segmen F, Aydemir S, Kucuk O, Dogu C, Dokuyucu R. Comparison of Oxidative Stress Markers with Clinical Data in Patients Requiring Anesthesia in an Intensive Care Unit. J Clin Med. 2024;13(22). https://doi.org/10.3390/jcm13226979
14. Margaritelis NV, Paschalis V, Theodorou AA, Vassiliou V, Kyparos A, Nikolaidis MG. Rapid decreases of key antioxidant molecules in critically ill patients: A personalized approach. Clin Nutr. 2020;39(4):1146-54. https://doi.org/10.1016/j.clnu.2019.04.029
15. Cakirca G, Damar Cakirca T, Ustunel M, Torun A, Koyuncu I. Thiol level and total oxidant/antioxidant status in patients with COVID-19 infection. Ir J Med Sci. 2022;191(4):1925-30. https://doi.org/10.1007/s11845-021-02743-8
16. Galijasevic M, Dervisevic A, Fajkic A, Avdagic N, Suljevic D. Platelet Mass Index and Other Platelet Parameters in the Assessment of Inflammatory Bowel Diseases Activity. Curr Health Sci J. 2021;47(4):566-74. Platelet Mass Index with Total Oxidant/Antioxidant Ugur Fahri Yurekli et al.
17. Chegondi M, Vijayakumar N, Billa RD, Badheka A, Karam O. Performance of Platelet Mass Index as a Marker of Severity for Sepsis and Septic Shock in Children. J Pediatr Intensive Care. 2023;12(3):228-34. https://doi.org/10.1055/s-0041-1731434
18. Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect. 2005;11(2):101-8. https://doi.org/10.1111/j.1469-0691.2004.01044.x
19. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123(6):2043-9. https://doi.org/10.1378/chest.123.6.2043
20. Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14(7):417-27. https://doi.org/10.1038/s41581-018-0005-7
